Autopsy report · NCT03248765

Human Brain Adaptation to Chronic Pain and Its Effects on Opioid Use

“Insufficient patient enrollment.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 3 years before it stopped.
• 10 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Washington University School of Medicine

Sponsor type

University, hospital or other

Conditions

Pain, Chronic; Opioid Use

Interventions

post-surgical opioid use measured at 1 day and 1 week.

Participants

10

Sites

1

Countries

United States

Trials that died the same way

• Intravitreal Dexamethasone Implant (Ozurdex) Versus Bevacizumab in Patients With Diabetic Macular Edema Undergoing Cataract Surgery
  “Inadequate patient enrollment” (88% match in meaning)
• Betadine Bladder Irrigations vs. Standard of Care Prior to Indwelling Catheter Removal
  “Lack of Patient Enrollment” (88% match in meaning)
• Implementing Cabenuva in Arkansas HIV Programs
  “Insufficient enrollment.” (88% match in meaning)
• Varenicline Treatment for Excessive Daytime Sleepiness in Parkinson's Disease
  “insufficient patient enrollment, insufficient funds for completion” (87% match in meaning)
• Neotililty Trial: Effect of Coenzyme Q10 on Semen Parameters in Men With Idiopathic Infertility
  “No further patient enrollment” (84% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.